Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

M.P. EVANS GROUP PLC Regulatory Filings 2019

May 1, 2019

7798_rns_2019-05-01_71b5907f-8e54-486e-ad10-472ef0b078ac.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7485X

M. P. Evans Group PLC

01 May 2019

M.P. Evans Group PLC (the "Company")

Total voting rights

In conformity with Rule 5.6.1 of the Disclosure Guidance and Transparency Rules, the Company notifies the market that as at the date of this announcement, the Company's issued share capital comprises 54,663,133 shares of 10p each ("Shares"). All of the Shares have equal voting rights and there are no Shares held in treasury.

This figure of 54,663,133 Shares represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

LEI number: 2138003IBXJUCR4SZG26

Enquiries:

M.P. Evans Group PLC                         Telephone: +44 (0) 1892 516333

Peter Hadsley-Chaplin, Chairman

Tristan Price , Chief Executive

Matthew Coulson, Finance Director

Peel Hunt LLP (NOMAD and joint broker)        Telephone: +44 (0) 20 7418 8900

Dan Webster

George Sellar

Guy Pengelley

finnCap (Joint broker)                                      Telephone: +44 (0) 20 7220 0500

Tim Redfern

Chris Raggett

Hudson Sandler (Financial PR)                        Telephone: +44 (0) 20 7796 4133

Charlie Jack

Bertie Berger

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

TVRBGGDULGGBGCB